Photocleavable crosslinker design, synthesis and analysis for enhanced crosslinking mass spectrometry methods

用于增强交联质谱方法的光裂解交联剂设计、合成和分析

基本信息

项目摘要

Crosslinking mass spectrometry is a multi-scale, protein behaviour determination technology. It is now an established and robust tool for elucidating structures of individual proteins and complexes. The method is currently under active development for use in the study of protein conformational changes and protein-protein interactions. Crucially, crosslinking mass spectrometry has the capacity to achieve all of the above, in the native environment in which proteins exist, the living cell. The method can also scale further, to systems level and proteome-wide analysis, on cell lysates, organelles and intact cells. However, higher levels of protein mixture complexity create new challenges for analysis.Crosslinking mass spectrometry technology is underpinned by the chemistry used to introduce covalent links, which preserve the critical spatial information. Crosslinker development is therefore a key driver of crosslinking mass spectrometry method development. Novel crosslinkers can enhance the analytical process with their interplay between data acquisition and data analysis approaches. Recent progress in ultraviolet photodissociation (UVPD) opens a new angle here, which we now want to exploit for crosslinking mass spectrometry. We will develop chemical crosslinkers with enhanced functionality (reactivity and crosslinker UV-cleavability), as well as new analytical and computational methods for better utilisation of the resulting data. We expect to achieve significantly greater depth for high-complexity protein analysis in crosslinking mass spectrometry analysis by improving signal-to-noise and will assess this in direct comparison to standard crosslinkers.
交联质谱是一种多尺度的蛋白质行为测定技术。它现在是一个建立和强大的工具,用于阐明单个蛋白质和复合物的结构。该方法目前正在积极开发中,用于蛋白质构象变化和蛋白质-蛋白质相互作用的研究。至关重要的是,交联质谱法有能力在蛋白质存在的天然环境(活细胞)中实现上述所有目标。该方法还可以在细胞裂解物、细胞器和完整细胞上进一步扩展到系统水平和蛋白质组范围的分析。然而,更高水平的蛋白质混合物复杂性给分析带来了新的挑战。交联质谱技术的基础是用于引入共价键的化学反应,这保留了关键的空间信息。因此,交联剂开发是交联质谱法开发的关键驱动力。新型交联剂可以通过它们在数据采集和数据分析方法之间的相互作用来增强分析过程。紫外光解离(UVPD)的最新进展在这里打开了一个新的角度,我们现在想利用交联质谱。我们将开发具有增强功能性(反应性和交联剂UV裂解性)的化学交联剂,以及新的分析和计算方法,以更好地利用所得数据。我们希望通过改善信噪比,在交联质谱分析中实现高复杂性蛋白质分析的更大深度,并将与标准交联剂直接比较进行评估。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Professor Dr. Juri Rappsilber其他文献

Professor Dr. Juri Rappsilber的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Professor Dr. Juri Rappsilber', 18)}}的其他基金

Capturing the organisation of the Mycoplasma pneumoniae proteome with in-cell crosslinking mass spectrometry
利用细胞内交联质谱法捕获肺炎支原体蛋白质组的组织
  • 批准号:
    426290502
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Functional and structural annotation of small proteins by advanced proteomics approaches
通过先进的蛋白质组学方法对小蛋白质进行功能和结构注释
  • 批准号:
    453130481
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
    Priority Programmes

相似海外基金

Combining Molecular Simulations and Biophysical Methods to Characterize Conformational Dynamics of the HIV-1 Envelope Glycoprotein
结合分子模拟和生物物理方法来表征 HIV-1 包膜糖蛋白的构象动力学
  • 批准号:
    10749273
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Bi-functional photo-crosslinking (BFPX) for genome-wide study of protein-nucleic acid interactions
双功能光交联 (BFPX) 用于蛋白质-核酸相互作用的全基因组研究
  • 批准号:
    10593666
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Decoupling Hydrogel Stiffness and Diffusivity for Hematopoietic Stem Cell Culture and Differentiation
用于造血干细胞培养和分化的水凝胶刚度和扩散率的解耦
  • 批准号:
    10647478
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Tissue Engineering Strategies to Revitalize Allografts
振兴同种异体移植物的组织工程策略
  • 批准号:
    10830613
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
A Generalizable Photo-Crosslinking Strategy to Identify Tyrosine Phosphatase Substrates
识别酪氨酸磷酸酶底物的通用光交联策略
  • 批准号:
    10612641
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Developing Therapeutic Gel Embolic Agents for Arteriovenous Malformation Embolization
开发用于动静脉畸形栓塞治疗的凝胶栓塞剂
  • 批准号:
    10667726
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Multi-parametric anthropomorphic MRI Phantoms technology for reliable and reproducible structural and quantitative MRI
多参数拟人 MRI Phantoms 技术可实现可靠且可重复的结构和定量 MRI
  • 批准号:
    10729161
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Novel antiviral strategy offering forward capability and reduced risk of escape
新颖的抗病毒策略提供前进能力并降低逃逸风险
  • 批准号:
    10593778
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Molecular Chaperone Recognition of CFTR Stability
CFTR 稳定性的分子伴侣识别
  • 批准号:
    10538012
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Molecular mechanism mediating apicobasal brain endothelial cells polarity in cerebral cavernous malformation type 3-lesion
脑海绵状血管瘤3型病变中顶基底层脑内皮细胞极性的分子机制
  • 批准号:
    10526456
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了